MedTrace Logo

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

NCT04951869 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-07-07

No results posted yet for this study

Summary

This study aimed to evaluate the effectiveness of Protescal in preventing post caesarean section hypertrophic scar and keloid formation.

Conditions

  • Caesarean Wound
  • Hypertrophic Surgical Scar
  • Keloid Scar Following Surgery

Interventions

DRUG

Protescal gel

Protescal gel (0.5 mL) was again applied over the subcutaneous tissue prior to skin closure in Protescal group

Sponsors & Collaborators

  • Universiti Kebangsaan Malaysia Medical Centre

    lead OTHER

Principal Investigators

  • Anizah Ali, MD(UKM),MOG(UKM) · UKMMC

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-26
Primary Completion
2017-10-31
Completion
2017-11-16

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04951869 on ClinicalTrials.gov